Astrana Health, Inc. ASTH
Set alert
37.01 USD +0.48 +1.31%
As of Nov 2, 3:05 PM ET
35.84 Day range 37.01
18.08 52-week range 51.60
- YTD
- +49.17%
- 1 year
- +18.58%
- Open
- 36.87
- Prev close
- 36.53
- Mkt cap
- 1.84B
- Vol
- 121.87K
- Avg vol
- 387.19K
- EPS
- 0.83
- P/E
- 44.59
- Div yield
- 0.00%
More statistics
- Low
- 35.84
- High
- 37.01
- Forward P/E
- 10.04
- Beta
- 1.03
- Short ratio
- 6.90
- Inst. own
- 66.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 37.13
- 200-d avg
- 33.78
- 1y target
- 51.67
1Y chart
Events in this range
- Nov 6, 2025Earnings: 0.01; estimate 0.47; surprise -97.87%
- Mar 2, 2026Earnings: 0.12; estimate 0.15; surprise -20%
- May 7, 2026Earnings: 0.3; estimate 0.29; surprise 3.45%
- Jul 14, 2026Rating: BTIG · Buy → Buy
- Jul 14, 2026Rating: TD Cowen · Buy → Buy
- Aug 6, 2026Earnings: 0.4; estimate 0.3358; surprise 19.12%
- Aug 7, 2026Rating: Barclays · Overweight → Overweight
- Aug 11, 2026Rating: Truist Securities · Buy → Buy
- Sep 15, 2026Rating: Oppenheimer · — → Outperform
- Oct 1, 2026Rating: Freedom Capital Markets · Buy → Buy
Signals (52)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Jul 31, 2026 | 3 months ago |
| RSI: Oversold | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Apr 9, 2026 | 6 months ago |
| RSI: Overbought | Apr 7, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 24, 2026 | 7 months ago |
| SMA: Bullish | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bullish | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Oversold | Feb 12, 2026 | 8 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| SMA: Bearish | Jan 16, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| RSI: Overbought | Jan 6, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 12 months ago |
| SMA: Bearish | Nov 7, 2025 | 12 months ago |
| RSI: Oversold | Nov 7, 2025 | 12 months ago |
Key statistics
- Market cap
- 1.81B
- Enterprise value
- 2.22B
- Trailing P/E
- 44.01
- Forward P/E
- 10.04
- PEG ratio
- 0.00
- Price / sales
- 0.47
- Price / book
- 2.17
- EPS (TTM)
- 0.83
- Beta
- 1.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.05%
- Revenue (TTM)
- 3.84B
- Revenue growth
- 48.50%
- Free cash flow
- 231.19M
- Total cash
- 400.79M
- Total debt
- 979.41M
- Return on equity
- 6.90%
- Shares outstanding
- 49.60M
- Short % of float
- 11.56%
- 50-day average
- 37.13
- 200-day average
- 33.78
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 51.67 +39.6% upside
Now 37.01
- Target (low)
- 41.00
- Target (mean)
- 51.67
- Target (high)
- 65.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy2
- Buy8
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.87667.
Financials — quick view
ASTH Revenue — quarterly 972.52M
ASTH Net income — quarterly 19.74M
ASTH EPS — quarterly 0.40
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.4573 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.3358 | 0.40 | +0.06 | +19.12% |
| May 7, 2026 | Mar 31, 2026 | 0.29 | 0.30 | +0.01 | +3.45% |
| Mar 2, 2026 | Dec 31, 2025 | 0.15 | 0.12 | -0.03 | -20.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.47 | 0.01 | -0.46 | -97.87% |
| Aug 7, 2025 | Jun 30, 2025 | 0.36 | 0.19 | -0.17 | -47.22% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 15, 2026 | Oppenheimer | init | — | Outperform |
| Aug 11, 2026 | Truist Securities | main | Buy | Buy |
| Aug 7, 2026 | Barclays | main | Overweight | Overweight |
| Jul 14, 2026 | TD Cowen | main | Buy | Buy |
| Jul 14, 2026 | BTIG | main | Buy | Buy |
About Astrana Health, Inc.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- astranahealth.com
News
- Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
- Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued
- Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
- Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
- Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts
Your note
Sign in to keep a note on ASTH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BASHO CHANDAN | Chief Operating Officer | Stock Award(Grant) | Mar 4, 2025 | 192,752 |
| CHIANG JOHN | Director | Stock Award(Grant) | Jun 9, 2026 | 35,373 |
| DONG LINDA | Director | Stock Award(Grant) | Jun 9, 2026 | 97,133 |
| KUMAR DINESH M | Officer | Stock Award(Grant) | Mar 31, 2026 | 177,655 |
| LAM THOMAS S | Director | Stock Award(Grant) | Apr 5, 2026 | 7,732,160 |
| MARSH LINDA | Director | Conversion of Exercise of derivative security | Nov 2, 2025 | 92,608 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 19.27% | 6,899,990 | 252.06M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.28% | 2,605,775 | 95.19M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.44% | 1,946,431 | 71.10M | Jun 29, 2026 |
| State Street Corporation | 4.86% | 1,738,930 | 63.52M | Jun 29, 2026 |
| 325 Capital Llc | 4.51% | 1,613,843 | 58.95M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 4.10% | 1,468,508 | 53.64M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.98% | 2,499,020 | 91.29M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.96% | 1,416,817 | 51.76M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 3.29% | 1,177,556 | 43.02M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.85% | 1,021,229 | 37.31M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.65% | 591,784 | 21.62M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.39% | 499,026 | 18.23M | Jul 30, 2026 |